Services to Ease FDA Regulatory Compliance

Monthly Archives: May 2017

self identification for FY 2019 May 4, 2017

FDA’s self identification period for fiscal year 2019  starts from 1st May 2019 and all the facilities involved in generic drug submission are  required to submit, update or re-confirm the self identification on or before 1st June 2019. CDER has started to send  email with below content to all the facilities  who have self identified … Continue reading self identification for FY 2019

Translate »